To evaluate the effects of a versatile web-based health game on cognition and compliance in Parkinson’s disease with mild cognitive impairment.
ID
Bron
Aandoening
mild cognitive impairment
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
cognition as measured by a standard neuropsychological assessment and online assessment
Achtergrond van het onderzoek
Cognitive impairment is an important non-motor symptom in PD and major determinant of the quality of life. The study aims to evaluate the effects of a versatile web-based health game on cognition and compliance in Parkinson’s disease with mild cognitive impairment.
Doel van het onderzoek
To evaluate the effects of a versatile web-based health game on cognition and compliance in Parkinson’s disease with mild cognitive impairment.
Onderzoeksopzet
baseline: t=0
12 weeks: t=1
24 weeks: t=2
Cognition is measured on all timepoints by calculating a z-score on a standard neuropsychological assessment and several self report questionnaires (HADS, CFQ, PD-CFR, Pre-R-ODS, PDQ39, and BIS-11).
Compliance is measured on all timepoints.
Motor symptoms are measured on all timepoints using the UPDRS-PD part III (motor symptoms).
Biological entpoints are measured on t=0 and t=1 in a subgroup of 40 participants using functional magnetic resonance imaging (fMRI).
Onderzoeksproduct en/of interventie
The intervention group receives a computerized cognitive training (health game) for a first period of 12 weeks. During this first period, the control group is placed on a waiting list. At the start of the second period of 12 weeks, both the intervention and the control group are allowed to receive the cognitive training.
Publiek
M. Kuijf
PO box 5800
Maastricht 6202 AZ
The Netherlands
Phone. 043 38 77056
Email. mark.kuijf@mumc.nl
Wetenschappelijk
M. Kuijf
PO box 5800
Maastricht 6202 AZ
The Netherlands
Phone. 043 38 77056
Email. mark.kuijf@mumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Diagnosis of idiopathic PD according to the UK Brain Bank Criteria,
Cognitive impairment at baseline in line with the Level 1 criteria for MCI and a cutoff of 1.5 SD below the normative mean,
Aged between 40 and 75 years old,
Not receiving any other cognitive therapy or intensified physical activity during the study,
Stable dopaminergic medication within last 3 months.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Hoehn & Yahr stage 4 or 5,
Advanced problems in cognitive functioning: Montreal Cognitive Assessment (MoCa) < 21/30,
Habitual gamers (>1hr games/week in preceding year),
Active depression or psychosis and/or treatment with antidepressant or antipsychotic drugs,
Medication interfering with cognition including anticholinergic medication, benzodiazepines not used as sleep medication and stimulants (i.e. methylphenidate),
Premorbid intelligence < 86 based on the Dutch National Adult Reading test (NART),
Severe auditory or visual deficits,
History of active thyroid disease, stroke with residual deficits, severe hypertension or diabetes or head trauma interfering in cognition,
Excessive daytime sleepiness (Epworth Sleepiness Scale score >10),
(MRI substudy exclusion: any piece of metal in the body, and/or claustrophobia).
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL5502 |
| NTR-old | NTR5637 |
| Ander register | MEC/IRB Maastricht : 141128 |